Oxford AstraZeneca Vaccine to be Sold to Developing Countries at Cost Price
- Aryaman Sinha

- Feb 5, 2021
- 1 min read

The coronavirus vaccine produced by Oxford University and AstraZeneca will be available on a non-profit basis “in perpetuity” to low- and middle-income countries in the developing world.
Photo Credit: Micheile Henderson




Comments